Evgeny Dyskin

Evgeny Dyskin

University of Minnesota Twin Cities - Minneapolis / United States
Medical and Health Sciences / Orthopedics and Traumatology
AD Scientific Index ID: 4681113
person_outline Evgeny Dyskin's MOST POPULAR ARTICLES
1-) Gold and silver nanoparticles conjugated with heparin derivative possess anti-angiogenesis properties MM Kemp, A Kumar, S Mousa, E Dyskin, M Yalcin, P Ajayan, RJ Linhardt, ... nanotechnology 20 (45), 455104, 2009 1542009
2-) Tetraiodothyroacetic acid (tetrac) and nanoparticulate tetrac arrest growth of medullary carcinoma of the thyroid M Yalcin, E Dyskin, L Lansing, DJ Bharali, SS Mousa, A Bridoux, ... The Journal of Clinical Endocrinology & Metabolism 95 (4), 1972-1980, 2010 1312010
3-) Tetraidothyroacetic acid (tetrac) and tetrac nanoparticles inhibit growth of human renal cell carcinoma xenografts M Yalcin, DJ Bharali, L Lansing, E Dyskin, SS Mousa, A Hercbergs, ... Anticancer research 29 (10), 3825-3831, 2009 1262009
4-) Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factorSA Mousa, JJ Bergh, E Dier, A Rebbaa, LJ O’Connor, M Yalcin, A Aljada, ...Angiogenesis 11, 183-190, 20081222008
5-) Potent pleiotropic anti-angiogenic effects of TM601, a synthetic chlorotoxin peptideDB Jacoby, E Dyskin, M Yalcin, K Kesavan, W Dahlberg, J Ratliff, ...Anticancer research 30 (1), 39-46, 2010772010